Quarterly Results

ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE922.20-14.1 (-1.51 %)
PREV CLOSE ( ) 936.30
OPEN PRICE ( ) 929.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 50355
TODAY'S LOW / HIGH ( )913.25 933.00
52 WK LOW / HIGH ( )482.55 1031.3
NSE922.15-14.85 (-1.58 %)
PREV CLOSE( ) 937.00
OPEN PRICE ( ) 920.25
BID PRICE (QTY) 922.15 (1761)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1482222
TODAY'S LOW / HIGH( ) 913.20 933.10
52 WK LOW / HIGH ( )484.95 1031.7
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
45052
43688
51396
50106
Total Expenditure
34234
33049
36343
37550
PBIDT (Excl OI)
10818
10639
15053
12556
Other Income
583
1362
360
378
Operating Profit
11401
12001
15413
12934
Interest
198
87
181
277
Exceptional Items
NA
NA
-142
-6013
PBDT
11203
11914
15090
6644
Depreciation
1948
1842
1798
1786
Profit Before Tax
9255
10072
13292
4858
Tax
2138
2264
2161
1372
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
7117
7808
11131
3486
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
7335
7798
11121
3464
Minority Interest
-3
-25
-467
-616
Shares of Associates
564
234
215
118
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
7896
8007
10869
2966
Equity Capital
1012
1012
1012
1012
Face Value (IN RS)
1
1
1
1
Reserves
NA
NA
NA
NA
Calculated EPS
7.80
7.91
10.74
2.93
Calculated EPS (Annualised)
31.20
31.64
42.96
11.72
No of Public Share Holdings
253263953
253263953
253263953
253263953
% of Public Share Holdings
25.02
25.02
25.02
25.02
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
24.01
24.35
29.28
25.05
PBIDTM%
25.30
27.46
29.98
25.81
PBDTM%
24.86
27.27
29.36
13.25
PBTM%
20.54
23.05
25.86
9.69
PATM%
15.79
17.87
21.65
6.95
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.